Living with ROS1-positive NSCLC

Stories from people navigating ROS1-positive NSCLC — diagnosis, treatment, caregiving, and the ordinary days in between.

1 story

A molecular lung cancer model beside a brain scan and targeted-therapy capsule in a clinical workspace.

Oncology

Zidesamtinib Offers a Post-TKI Option in ROS1 NSCLC

Accelerated approval places zidesamtinib after a prior ROS1 tyrosine kinase inhibitor, with reported activity in systemic and intracranial disease but no randomized evidence yet.

Rayan Salih · September 9, 2026 · 6 min

Other conditions

ADHD
Allergy
ALS
Alzheimer's Disease
Antimicrobial Resistance
Anxiety
Asthma
Atopic Dermatitis
Atrial Fibrillation
Autism
Breast Cancer
Cervical Cancer

One story a day

The story of the day, in your inbox

One health journey each morning — no advice, no alarm, just company for the road.